Protagonist Therapeutics grants inducement equity awards to new hires, sets option exercise price at $135.46
PTGX•Inducement equity awards for new hires
Protagonist Therapeutics granted inducement equity awards on July 15, 2026 to three newly hired employees.
- Awards total stock options for 12,600 shares, RSUs for 3,330 shares.
- Options carry an exercise price of $135.46, set at the Nasdaq closing price on July 15, 2026.
- Options vest over four years, starting with 25% on the first anniversary of hire, then monthly over three years.
- RSUs vest 25% annually over four years.
